Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

This Nvidia-Backed AI Stock Is Shrugging Off Market Pain Thanks to the FDA. Should You Buy Shares Now?

Recursion Pharmaceuticals (RXRX) shares closed up 27% after the Food and Drug Administration (FDA) said it wants to phase out animal testing in drug development. 

The U.S. regulatory authority wants to switch to “more effective, human-relevant methods” instead, including machine learning and artificial intelligence, according to its press release on Friday. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.